Stock AVTX AVALO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Avalo Therapeutics, Inc.

Equities

AVTX

US05338F3064

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-07-08 pm EDT 		5-day change 1st Jan Change
13.15 USD +4.45% Intraday chart for Avalo Therapeutics, Inc. +4.28% +44.51%
Jun. 24 Avalo Therapeutics Names Chief Legal Officer MT
Jun. 24 Avalo Therapeutics, Inc. Appoints Paul Varki as Chief Legal Officer CI

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cerecor Inc. Provides Revenue Guidance for the Year 2019
CI
Cerecor Inc. Reaffirms Earnings Guidance for the Full Year 2019; Announces Impairment Charges for the Second Quarter Ended June 30, 2019
CI
Cerecor Inc. Provides Revenue Guidance for the Full Year 2019
CI
Cerecor Inc. Provides Earnings Guidance for the Full Year of 2019
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AVTX Stock
  4. News Avalo Therapeutics, Inc.
  5. Transcripts